...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: New trial
3
May 25, 2021 10:36PM

"That timeline seems to line up with the conclusion of these ongoing trials."

Surely,... not by design!!

 

Koo

3
May 26, 2021 01:25PM
2
May 26, 2021 02:56PM
4
May 27, 2021 04:13PM
4
May 28, 2021 10:57PM
3
May 28, 2021 11:12PM
3
May 29, 2021 10:08AM
2
May 29, 2021 10:12AM
Share
New Message
Please login to post a reply